In the present study, the NI had a higher AUROC and higher sensitivity, specificity, and accuracy than ECPKA‐Ab alone (Figure 2, Table 4), indicating that ECPKA‐Ab is a more powerful biomarker of cancer when combined with CRP. This evidence concerns the gene CRP and cancer.